Adherium submits US FDA 510(k) application for next generation Hailie® sensor with physiological measures
/in AdheriumLink to Full Article Melbourne, Australia – 1 June 2021: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced submission to the US Food and Drug Administration (FDA) of a 510(k) clearance to market application for its first next generation Hailie® sensor with physiological measures for monitoring Asthma […]
Adherium announces appointment of Mr. Rick Legleiter as Chief Executive Officer and welcomes Mr. George Baran to the Board
/in AdheriumLink to Full Article Melbourne, Australia – 13 May 2021: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, announces the appointment of Rick Legleiter as Chief Executive Officer of Adherium. The Board also announces the appointment of George Baran as a Non-Executive Director. Mike Motion, Adherium’s current CEO and […]
Adherium Quarterly Cash Flow Report to 31 March 2021
/in AdheriumLink to Full Article All figures are stated in Australian dollars and are unaudited. Adherium Limited (ASX: ADR), a leader in digital inhaled device adherence, remote monitoring, and data management solutions, presents its Appendix 4C cash flow report for the quarter ended 31 March 2021. During the quarter Adherium received $18 million of investment commitments […]
Adherium introduces Hailie® technology into specialist USA respiratory centres with leading USA respiratory company
/in AdheriumLink to Full Article Melbourne, Australia – 24 November 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, is pleased to announce agreement of terms with leading respiratory company Monaghan Medical Corporation (Monaghan) to support the introduction of its Hailie® platform and technology into specialist respiratory centres in […]
Adherium Annual Report
/in AdheriumLink to Full Report
Adherium appoints Mr Geoff Feakes as Chief Technology Officer
/in AdheriumLink to Full Article Melbourne, Australia – 5 August 2020: Adherium Limited (ASX: ADR) a leader in digital inhaled device adherence, remote monitoring and data management solutions, has appointed Mr Geoff Feakes as Chief Technology Officer (CTO) leading the Company’s R&D and Innovation teams supporting Adherium’s revised business strategy. Mike Motion, Adherium CEO noted: “I […]
Cleansing notice under section 708A of the Corporations Act 2001 (Cth)
/in AdheriumLink to Full Article Adherium Limited ACN 605 352 510 (Company) (ASX: ADR) has undertaken an allotment of fully paid ordinary shares (Shares) under its Employee Share Plan. Details of the allotment are contained in the Appendix 2A filed by the Company on 30 June 2020. The Company gives notice pursuant to section 708A(5)(e) of […]
Adherium progresses U.S. sales agreement with respiratory device U.S. market leader Monaghan Medical Corporation, a member of the Trudell Medical Group of Companies
/in AdheriumLink to Full Article Melbourne, Australia – 29 April 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, has signed a heads of terms sales agreement with Monaghan Medical Corporation, a US subsidiary of Trudell Medical Limited, the parent company of a multinational group of leading companies […]
Adherium announces appointment of Mr. Mike Motion as Chief Executive Officer and Ms. Anne Bell as Chief Financial Officer
/in AdheriumLink to Full Article Melbourne, Australia – 24 April 2020: Adherium (ASX:ADR) today announced the promotion of Mr Mike Motion from Chief Operating Officer to the role of Chief Executive Officer, replacing Mr Jeremy Curnock Cook who has held the position on an interim basis. Mike will also join the Board as an Executive Director, […]